Document:

Filed by Automated Filing Services Inc. (604) 609-0244 - REGI U.S. Inc. - Exhibit 10.1

Exhibit 10.1

REGI US AGREEMENT

THIS AGREEMENT made as of the _____day of ___________,
2005.

BETWEEN:

  
    
      
        
          REGI U.S., INC., an Oregon corporation, Having
            an office at #1103, 11871 Horseshoe Way, Richmond, B.C. Canada
            V7A 5H5 

          (hereinafter referred to as "REGI US")

        

      

    

  

OF THE FIRST PART 

AND: 

  
    
      
        
          ANUVU INCORPORATED, a California corporation
            Having an office at 3980 Research Drive Sacramento, CA 95838 

          (hereinafter referred to as "ANUVU") 

        

      

    

  

OF THE SECOND PART

WITNESSETH

WHEREAS:

	 	A. 	ANUVU holds the sole and exclusive rights throughout
        the United States to the use of the Technology hereinafter described;
      

	 	 	 
	 	B. 	ANUVU is a provider of services, systems and equipment
        to or for the benefit of the “ANUVU’s Fuel Cell Technology”;
      

	 	 	 
	 	C. 	REGI US has examined certain preliminary information
        of technical data provided to it by ANUVU concerning the Technology and
        wishes to obtain an exclusive distributorship for Canada and an option
        to purchase the same for Europe. 

NOW THEREFORE in consideration of the premises and the mutual
covenants, conditions and agreements hereinafter set out and other good and
valuable consideration not recited herein, the parties hereto agree as
follows:

Article I — Definitions

The following terms (except as otherwise expressly provided or
unless, the context otherwise requires) for all purposes of this Agreement shall
have the following respective meanings (it being understood that the terms
defined in this Agreement shall include in the singular number the plural, and
in the plural number the singular).

1.01      “Affiliate” shall
mean any corporation or other entity which either directly or indirectly
controls a party to this Agreement, is controlled by such party, or is under
common control with such party. As used here, the term “control” means
possession of the power to direct or cause the direction of the management and
policies of a corporation or other entity, whether through the ownership of
voting securities, by contract or otherwise.

1.02      “Agreement”
shall mean this Agreement, including all exhibits and schedules annexed to this
Agreement.

1.03      “Distributorship
Patents” “Patents” means the Patents described in Schedule “A” hereto and
all other patents and patent applications of all countries which contain claims
covering one or more features 

	Distributorship Agreement 	Page 1 of 11 

of the Technology and which are based on Inventions conceived,
acquired or reduced to practice by or on behalf of ANUVU and includes any and
all renewals, divisions, continuations, continuations-in-part, reissues,
extensions, additions, corresponding international patent applications, and any
and all future patent applications, and any and all future patent applications
on patents issues in respect thereof. 1.04 “Products” “Product” means any
product, heretofore or hereafter existing, which utilizes, embodies or is based
on the ANUVU Fuel Cell Technology.

1.05      “Territory” shall
mean Canada and Europe (Europe to be defined as the member nations of the
European Union as of the date of this document).

1.06      “Invention” means
discoveries, concepts, and ideas, whether patentable or not, including but not
limited to processes, methods, formulae and techniques as well as improvements
thereto and extensions thereof.

1.07      “Know-how” includes
all technical information, trade secrets, procedures, composition, processes,
methods, practices, diagrams, drawings, specifications, blue-prints, plans,
materials, documents, manuals and data relating to the design, manufacture,
production, distribution and testing of a products or Invention.

1.08      “Party” means each of
REGI US and ANUVU, and “Parties” means both REGI US and ANUVU. 1.09
“Prototype” means a fully functional prototype of a fuel cell prototype
which utilizes and embodies the Technology.

1.10      “Technology” means
the technology which is the subject of the Patents and all other knowledge,
Know-how and Inventions owned, controlled, developed or acquired by or on behalf
of ANUVU relating thereto, including without limitation the composition,
formulation, construction, characteristics, uses and physical manifestations
thereof.

Article II — Grant of Distributorship

2.01      REGI Distributorship
Patents. ANUVU hereby grants and agrees to grant REGI US and its Affiliates,
and REGI US and its Affiliates accept, an exclusive Distributorship, under the
Distributorship in the Territory with the right to grant subDistributorships, to
use and sell the technology and to use, sell and have sold the Products in the
Territory. The Distributorship shall include, but not be limited to, all
products and devices presently and in the future conceived and developed by
ANUVU, as well as all improvements on existing technology, devices and products
for an payment in the amount of One Hundred Thousand Dollars ($100,000.00) as
defined in Article III, and an additional payment on or before July 31, 2005 of
One Hundred Thousand Dollars ($100,000.00), totaling Two Hundred Thousand
Dollars ($200,000.00) as payment in full for the Canadian Distributorship.

2.01(a) ANUVU agrees to grant to REGI US an option to an
exclusive Distributorship Agreement for Europe as part of this Agreement and
REGI US may exercise a set option for the European Distributorship for payments
of Three Hundred Thousand Dollars ($300,000.00) of which One Hundred and Fifty
Thousand Dollars ($150,000.00) is to be paid within 90 days from the date of
this Agreement and the final payment of One Hundred and Fifty Thousand Dollars
($150,000.00) is to be paid on or before November 30, 2005. REGI US agrees to
issue 200,000 treasury shares of REGI U.S., INC. upon confirmation of acceptance
of the European fuel cell technology patents contemplated to be applied for in
section 2.01 (b) .

2.01(b) ANUVU agrees to use its best efforts to submit a patent
  application for Canada and Europe based on the current fuel cell technology
  claims set forth in claims of the U.S. Patents Pending held by the ANUVU before
  the deadline date by the said Patent Office. Patents will be owned by ANUVU
  and used exclusively in the Territory by the REGI US during the term of this
  Agreement. ANUVU and REGI US agree to file the Canadian Patent Application on
  or before November 7, 2005.
	Distributorship Agreement 	Page 2 of 11 

2.01(c) Upon approval of ANUVU’s Secured Lender, this Agreement
automatically converts into a license agreement: ANUVU agrees that upon Patent
approval the distribution rights will be transferred into a Patent License
Agreement upon the written consent of REGI US. The terms and conditions of the
License Agreement will be mutually agreed upon in a new Patent License
Agreement. In addition, in the event the secured lenders’ note in the amount of
$3,500,000.00 is retired this Distribution Agreement automatically converts to a
Patent License Agreement.

2.01(d) ANUVU agrees to issue two (2) warrants of Anuvu to REGI
US in consideration for each US$1.00 payment to ANUVU, pursuant to paragraph
2.01 and 2.01(a) of this Agreement, in additional consideration for payments
under this Agreement. Warrants to be issued within 60 days of the completion of
the payments for each Distributorship. Each warrant will entitle REGI US to
purchase one (1) treasury share of Anuvu for US$0.01 for a period of one year
from the date of payment.

2.01(e) ANUVU agrees to build a working fuel cell model
prototype for REGI US for demonstration purposes in a vehicle in Canada. The
vehicle to be selected by consent of both ANUVU and REGI US, to be completed
within 90 days of payment for the Canadian exclusive license. REGI US to pay all
costs associated with prototype including hardware, labor, overhead, export
duties and licensing fees. Costs to be agreed upon by both parties before work
is to commence. 

2.01(f) Upon approval of ANUVU’s Secured Lender and based on
REGI US paying the license fees for one or more countries noted in paragraph
2.01 and 2.01(a), ANUVU will grant the sole and exclusive right and license, for
each country paid by REGI US, to use the Technology for the purposes of
manufacturing for the purposes of manufacturing products in Canada, Europe and
the sole and exclusive right to sell, sublicense and distribute such products to
the countries that REGI US make the agreed payments to subject to a five percent
(5%) net royalty. ANUVU will continue to develop the Technology for REGI US, on
behalf of its customers and contacts, under the license agreement for those
countries for a period of five (5) years, and renewable for an additional five
(5) years based on the election of REGI US.

2.01(g) REGI US will agree to pay for the patent application
costs and associated legal fees for Canada and Europe.

2.01(h) ANUVU agrees that REGI US will have a 30 day first
refusal to purchase Anuvu shares in event the additional shares to be issued or
purchased by Anuvu for any reason at the same price that any investor may agree
to pay/sell for the said shares for a period of 6 months.

2.01(i) ANUVU will agree to work on the Rand CamTM technology
projects as required by REGI US, under a contract basis.

2.01 (j) Transfer of Product from ANUVU to REGI US will occur
by way of a purchase order being submitted by REGI US to ANUVU that will define
prices, delivery dates, freight charges, taxes, tariffs, export issues and
payment terms. 

2.02      Trademarks. REGI US
and its Affiliates shall be free to sell products using the Distributorship
Patents, and shall be free to Register trademarks and tradenames with respect to
such products under any trademark selected or Registered by REGI US or any of
its Affiliates in any country in the Territory, and all trademarks, tradenames,
slogans, logos, trade dress and goodwill owned or developed by REGI US or
associated with the Distributorship Patents shall be the sole and exclusive
property of REGI US or its Affiliates.

2.03      Right of First Refusal
  on Technology. Upon approval of ANUVU’s Secured Lender, ANUVU hereby
  grants to REGI US and its Affiliates a right of first refusal to exclusively
  use, manufacture, develop, sell, market and distribute products based on new
  patents and applications for patents, improvements, technology, products, devices,
  know-how, inventions, ideas, methods, processes and concepts, which are owned
  or developed by ANUVU and are not included in the Distributorship Patents (“New
  Technology”) in consideration for 100,000 treasury shares of REGI U.S.,
  INC.. At the time when ANUVU develops any such New Technology, ANUVU shall offer
  to REGI US, in writing, the right to use, manufacture, develop, sell, market,
  and distribute products based on such New Technology, 

	Distributorship Agreement 	Page 3 of 11 

describing in sufficient detail the nature of such New
Technology. REGI US and ANUVU shall discuss the offer, negotiating its terms in
good faith, and ANUVU shall memorialize an offer to REGI US in writing based on
such discussions (“Offer”). From the date the Offer is received, REGI US
shall have sixty (60) days within which to accept the Offer which acceptance
shall also be in writing. If REGI US declines the Offer, ANUVU shall be free to
solicit other interest in the New Technology proposed. However, prior to
licensing any such New Technology to a third party, ANUVU shall offer REGI US in
writing the same terms and conditions on which the proposed Distributorship to
the third party is based and REGI US shall have thirty (30) days in which to
meet the terms and conditions of such proposed Distributorship, which shall be
done in writing.

Article Ill — Royalties

3.01      Royalties. REGI US
shall pay ANUVU a royalty of five percent (5%) of the Adjusted Gross Sales Price
of any Products sold by REGI US or its Affiliates for which REGI US receives
payment (“Royalties”). “Adjusted Gross Sales Price” shall mean the gross sales
price of any Products sold less returns and reasonable actual discounts or
rebates.

3.02      Payment of Royalties.
REGI US shall pay ANUVU the Royalties on the first day of the first month of
each calendar quarter during the Term.

3.03      Adjustment of
Royalties. REGI US shall have the right to decrease the Royalties formula if
(i) products similar to the Products have come to market in any particular
country of the Territory, and (ii) the total market share of all such products,
even if manufactured by different companies, which are similar to any of the
Products is thirty percent (30%) or more. The adjustment in the Royalties
formula shall be negotiated in good faith between REGI US and ANUVU. In the
event no agreement is reached within ten (10) days after adjustment is requested
by REGI US, then the parties shall submit the issue of Royalties formula
adjustment, pursuant to this Paragraph 3.03, for final resolution to the
American Arbitration Association, in accordance with its Commercial Rules, whose
determination shall be final and binding on REGI US and ANUVU.

3.04      Inspection. ANUVU
shall be permitted at reasonable times, and upon at least three (3) days prior
written notice to REGI US, to inspect the books and records of REGI US as such
relate to sales of the Products for the purpose of determining the accuracy of
the Royalties paid to ANUVU pursuant to this Article III.

3.05      Conversion from REGI US
Agreement to License Agreement. Upon approval of ANUVU’s Secured Lender,
this Agreement automatically converts into a License Agreement.

Article IV — Product Development, Inspections and
Audits

4.01      Product
Development

	 	(a) 	ANUVU shall have the responsibility for, and shall
        use its utmost best efforts is and entire human and economic resources
        exclusively for, developing commercially viable products and product prototypes
        using the Distributorship Patents (“Product Development”)
        improving the Distributorship Patents and developing new technology and
        new patents. The advance royalties will be used by ANUVU for Product Development,
        including building a working fuel cell model prototype for REGI US. 

	 	 	 
	 	(b) 	REGI US shall, market, use, sell and distribute the
        Products within the Territory. Upon conversion to a licensing agreement
        REGI US shall have the right to manufacture the Products within the Territory.
        ANUVU shall disclose to REGI US all information concerning the Distributorship
        Patents and Products, and all information concerning Product Development
        as required by REGI US, including but not limited to proprietary engineering,
        design, clinical and technical data, methods, processes which is necessary
        for evaluation or production of the Products, whether presently within
        the knowledge and possession of ANUVU and its employees or which comes
        within the knowledge and possession of ANUVU and its employees in the
        future and during the Term of this 

	Distributorship Agreement 	Page 4 of 11

	 		Agreement. ANUVU shall fully cooperate with REGI
        US, in the event REGI US elects to test any of the products and product
        prototypes developed by ANUVU using the Distributorship Patents, including
        but not limited to Institutional Review Board testing and other formal
        and informal testing procedures. 

	 	 	 
	 	(c) 	Nothing in this Paragraph 5.01 shall preclude REGI
        US from using third parties under a subDistributorship or by contract
        to manufacture, market, and distribute the Products. 

4.02      Inspections and Board
Member.

	     	(a)     	REGI US shall have
        the right to have its representatives inspect and audit the Patent Holder
        facilities, premises, and books and records as reasonably required by
        REGI US. ANUVU shall cooperate with REGI US fully in all such inspections
        and audits.

	 	  	 
	 	(b) 	ANUVU shall, within 30 days
        of the date of this agreement, present to REGI US a voting agreement based
        on the approval of the ANUVU’s shareholders which will give REGI
        US the right during the Term to designate one member of the ANUVU Board
        of Directors to be voted by the shareholder’s by way of the voting
        agreement. 

Article V — Representations and Warranties

5.01      Representations and
Warranties of ANUVU. ANUVU hereby represents and warrants the following to REGI
US as of the date of this Agreement:

	 	(a) 	ANUVU is a corporation duly organized, validly existing
        and in good standing under the laws of the State of California. 

	 	 	 
	 	(b) 	ANUVU has full corporate power and authority to enter
        into and perform this Agreement. The execution, delivery and performance
        of this Agreement by Patent Holder have been duly authorized by all requisite
        corporate action. A Board of Directors’ resolution approving the
        execution, delivery and performance of this Agreement is annexed to this
        Agreement as Exhibit B. 

	 	 	 
	 	(c) 	ANUVU is the sole owner of all right, title and interest
        in and to the 

	 	 	 
	 		Distributorship Patents, and ANUVU has legal power,
        authority and right to grant the exclusive Distributorship under the Distributorship
        Patents. 

	 	 	 
	 	(d) 	To ANUVU’s knowledge, there are no patents owned
        by others and no other proprietary rights or property of others which
        would be infringed or misused by REGI US or its Affiliates or subREGI
        USs as a result of their exercise of the rights in and to the Distributorship
        Patents and the products granted by this Agreement. 

	 	 	 
	 	(e) 	There are no actions, suits, or claims pending against
        ANUVU or its Affiliates in any court or by or before any governmental
        body or agency with respect to the Distributorship Patents or Products,
        and to the best of ANUVU’s knowledge, no such actions, suits or claims
        have been threatened against ANUVU or its Affiliates other than those
        in Exhibit C (ASK Note). 

	 	 	 
	 	(f) 	ANUVU has no knowledge of any infringement of the
        Distributorship Patents or knowledge of any claim or allegation, or any
        basis thereof, of patent infringement or misuse of any confidential information
        with regard to the Distributorship Patents or Products. 

	 	 	 
	 	(g) 	No other person or organization presently has any
        effective assignment, option, Distributorship or subDistributorship under
        the Distributorship Patents or with respect to 

	Distributorship Agreement 	Page 5 of 11 

	 		the manufacture, use or sale of the Products or other
        products using the Distributorship Patents with in the Territories. 

	 	 	 
	 	(h) 	The Distributorship Patents include all of the patents,
        applications for patents, improvements, technology, products, foreign
        counterparts and extensions thereof, know-how, inventions, ideas, concepts,
        methods and processes presently owned, used or developed by ANUVU in the
        development of fuel cell technology. 

	 	 	 
	 	(i) 	ANUVU’s facilities, equipment and operations
        are in material compliance with all applicable laws and regulations in
        the United States. ANUVU holds all material Distributorships, permits
        and other governmental authorizations necessary or required by ANUVU to
        conduct its operations and business in the manner presently conducted
        in the United States. 

5.02      Representations and
Warranties of REGI US. REGI US hereby represents and warrants the following
to ANUVU as of the date hereof:

	 	(a) 	REGI US is a corporation duly organized and validly
        existing under the laws of the State of Oregon. 

	 	 	 
	 	(b) 	REGI US has full corporate power and authority to
        enter into and perform this Agreement. The execution, delivery and performance
        of this Agreement by REGI US have been duly authorized by all requisite
        corporate action. 

	 	 	 
	 	(c) 	REGI US has the financial resources to make all payment
        in a timely manner based on the dates with in this document. 

	 	 	 
	 	(d) 	REGI US upon execution of this Agreement will actively
        engage in the distribution, marketing or manufacturing of other PEM Fuel
        Cell Stack technology. 

5.03      Survival. The
foregoing representations and warranties of the parties shall survive
termination or expiration of this Agreement.

Article VI — Indemnification

6.01      ANUVU
Indemnification. ANUVU shall indemnify and hold REGI US harmless against any
and all liabilities, damages, losses, costs, expenses, claims, suits, recoveries
and judgments (including attorneys’ fees and expenses) of REGI US, its
Affiliates or any third party resulting from or arising out of (i) a breach of
ANUVU of any of its obligations, covenants or agreements under this Agreement,
(ii) the failure of any of the representations and warranties made by ANUVU
under this Agreement to be true and correct as of the date hereof, (iii) any act
or omission on the part of ANUVU or any of its employees or Affiliates or agents
in the performance of this Agreement, and (iv) patent infringement claims
relating to the Distributorship Patents, to the extent provided in Article VIII
of this Agreement below.

Article VII — Patent Prosecution and Infringement

7.01      Prosecution. ANUVU
shall keep REGI US currently advised of all steps taken or to be taken in the
prosecution of all applications for patents and improvements included in the
Distributorship Patents, and shall furnish REGI US with copies of all such
patent applications promptly after filing. REGI US shall be responsible for all
fees with respect to such patent applications and all fees necessary for the
maintenance of the Distributorship Patents in the Territory. ANUVU shall consult
with REGI US with respect to the prosecution of such patent applications or
patents resulting therefrom.

7.02      Infringement
Actions.

	 	(a) 	REGI US and ANUVU shall each promptly notify the
        other following the discovery of any infringement of the Distributorship
        Patents or unauthorized use of the Products which may come to their attention.
        ANUVU shall promptly make all efforts to obtain a discontinuance of the
        infringement and, if not successful, Patent Holder shall bring suit against
        the infringer. 

	Distributorship Agreement 	Page 6 of 11 

	 	(b)          
            	If ANUVU falls to obtain a discontinuance
        of such infringement or unauthorized use and/or fails to bring an infringement
        suit within thirty (30) days after discovery of such infringement or unauthorized
        use (“Initial Period”), then ANUVU shall give notice
        in writing to REGI US within fifteen (15) days following the Initial Period
        of such failure, and REGI US may, but is not required to, obtain a discontinuance
        of the alleged infringement or unauthorized use or bring an infringement
        suit. Any infringement suit brought by REGI US shall be in the name of
        ANUVU or   REGI US, or jointly in the name of ANUVU and REGI
        US, as REGI US shall elect in its sole discretion, or as required by the
        law of the forum. 

	 	  	  
	 	(c)          
              	With respect to any suit for
        infringement of the Distributorship Patents or unauthorized use of the
        Products, the party that did not institute suit shall render all reasonable
        assistance to the party that did institute suit including, but not limited
        to, executing all documents as may be reasonably requested by the party
        that did institute suit. In the event REGI US institutes suit, REGI US
        shall be entitled to reimbursement from ANUVU for all of its reasonable
        attorneys’ fees, costs and expenses, including the expenses of any
        expert witnesses that may be retained (“Infringement Expenses”),
        which Patent Holder shall pay upon demand from REGI US, and REGI US may
        deduct such Infringement Expenses from any and all sums, including Royalties,
        which REGI US owes ANUVU, on a first priority basis. 

7.03      Infringement of Third
Party Patents. Each party shall notify the other promptly in the event of
the receipt of notice of any action, suit or claim alleging infringement by the
manufacture, use or sale of the Products, or of any patent or proprietary right
held or alleged to be held by a third party. ANUVU shall indemnify and hold REGI
US, its Affiliates and subREGI USs, harmless from all damages, losses, costs,
expenses, claims, suits, recoveries and judgments (including attorneys’ fees,
expenses, costs and expert witness fees) related thereto. This indemnification
obligation shall survive the termination of this Agreement.

7.04      Offset. In the event
it is necessary, in REGI US’s judgment, for REGI US to make royalty or other
payments to a third party in order for REGI US to exercise or continue to
exercise any rights granted to REGI US pursuant to the terms of this Agreement
in relation to the Distributorship Patents and Products, REGI US shall be
entitled to offset any amounts so paid to any third party against amounts due or
which may become due to ANUVU under this Agreement if REGI US give notice to
ANUVU of such third party claim 60 days before any offset cost adjustments are
made and ANUVU has ability to make other arrangements with third party.

Article VIII — Confidentiality

8.01      “Confidential Information”
means:

	   	(a)   	all written information
        (including information orally disclosed but promptly thereafter reduced
        to writing) that is marked as “Confidential” by a Party (in
        this section 8.1, the “Discloser”); and 

	 	  	
	         	(b)         	all information
        not generally known to the public, whether disclosed orally or in any
        tangible form (including magnetic or electronic), relating to any technology,
        products, processes and concepts created, developed or acquired by or
        on behalf of the Discloser or its affiliates, including but not limited
        to patents and patent applications, Inventions, Know-how, prototypes,
        samples, research and manufacturing processes; 

	 	 	 
	 	but shall not include information that:
    
	 	 	 
	   	(c)   	is, or becomes generally
        know to the public, through no wrongful act of the other Party (in this
        Section 8.1, the “Recipient”); 

	Distributorship Agreement 	Page 7 of 11

	 	(d) 	can be shown by documentation to have been rightfully
        received by the Recipient from a third party who is free to disclose it
        without obligation to the Discloser and who did not acquire such information
        by a wrongful act; or 

	 	 	 
	 	(e) 	can be shown by documentation to have been independently
        developed by the receiving Party without reference to any other Confidential
        Information. 

8.02      During the Term and for a
period of five (5) years thereafter, each of the parties and their respective
employees, agents, directors, officers, Affiliates and subREGI USs shall hold in
confidence all confidential or proprietary information of the other party
disclosed hereunder (“Information”) except for and to the extent that
such Information (i) is or becomes generally available to the public through no
fault of the receiving party; (ii) can be demonstrated in writing to have been
known by the receiving party at the time of its disclosure by the other party or
is independently developed after the date of disclosure by the receiving party
without the application or use of the Information; (iii) becomes known to the
other party from a source other than the disclosing party without breach of this
Agreement by such party, provided, that such other source has the lawful right
to disclose such Information, or (iv) is disclosed pursuant to a final, binding,
nonappealable order or requirement of a court, administrative agency or other
government body.

8.03      Each Party acknowledges
that in the course of carrying out this Agreement, it may be provided with
access to and be entrusted with Confidential Information of the other Party, the
unauthorized disclosure of any of which to competitors of the other Party or to
the general public would be highly detrimental to the other Party, and each
Party further acknowledges and agrees that the right to maintain the
confidentiality of such information constitutes a proprietary right which the
other party is entitled to protect.

8.04      Each Party agrees to keep
  and use the Confidential Information of the other Party, howsoever obtained,
  strictly confidential at all times and shall not now or in the future, without
  the prior written consent of the other Party, disclose the other Party’s
  Confidential Information to any person or entity other than: 

(a) to such of its directors, officers, employees and professional
  advisors as shall have a need to know such Confidential Information in order
  to assist such Party in performing its obligations under this Agreement; or

(b) to a person or entity pursuant to a judicial or regulatory
  process or other requirement of law; provided however that in such case, the
  legally compelled Party shall be obliged to promptly notify the other Party
  in writing prior to making any such disclosure, and shall in any event disclose
  only that portion of the other Party’s Confidential Information which is
  legally required to be disclosed and shall exercise all reasonable efforts to
  ensure that confidential treatment will be accorded such Confidential Information.

8.05      Each Party agrees that
it will require all of its officers, employees or consultants who have or will
be granted access to Confidential Information to execute mutually acceptable
assignments of inventions agreements and mutually acceptable Confidentiality and
Non-Circumvention Agreements prior to being granted access to Confidential
Information.

8.06      Each Party agrees to take
all reasonable precautions to avoid disclosure or dissemination of the other
Party’s Confidential Information other than as permitted herein, and to limit
and control any copies, extracts or reproductions made of any such Confidential
Information, and shall otherwise safeguard such Confidential Information to the
same extent as it does its own secret information.

Article IX — Arbitration

9.01      Any dispute between the
parties in respect of any matter arising under this Agreement or in relation to
the construction hereof shall be submitted to arbitration and determined by a
single arbitrator appointed pursuant to the Rules of Commercial Arbitration
Association (the “Rules”) which arbitrator shall preside over the arbitration
and conduct it in accordance with the Act, determine all questions of 

	Distributorship Agreement 	Page 8 of 11 

procedure not provided for under the Rules or herein, and
render a decision which the parties hereby agree shall be final and binding upon
the parties; provided however that not withstanding anything else herein
contained:

	 	(a) 	it shall be a condition precedent to the right of
        either Party to submit any matter to arbitration, that such Party shall
        have given the other Party not less than ten (10) days’ prior notice
        of its intention to do so together with particulars of the matter in dispute;
      

	 	 	 
	 	(b) 	the arbitral venue shall be at the offices of the
        American Arbitration Association located in Los Angeles; 

	 	 	 
	 	(c) 	the arbitral award shall not grant any punitive,
        consequential, remote or incidental damages; and 

	 	 	 
	 	(d) 	the arbitral award shall be final, binding and conclusive.
      

	 	 	 
	 	(e) 	The substantially prevailing Party will be entitled
        to recover its reasonable costs incurred in connection with such action
        including attorneys’ fees and disbursements (valued at market rates
        for comparable services from private practitioners), costs of discovery
        and court costs. 

Article X — Miscellaneous

10.01      Governing Law.
This Agreement shall be covered by and construed in accordance with the laws of
the State of California other than provisions relating to conflicts of law
provided, however, that all questions concerning the construction or effect of
any patent applications or patents shall be decided in accordance with the laws
of the country or territory in question. Each party hereto submits to the
jurisdiction of the courts of the State of California, County of Sacramento, or
to the United States District Court in connection with any matter relating to
this Agreement.

10.02      Term of
Agreement. This Agreement will be in full force and effect until such time
as the Patents referred to herein and any extensions or derivatives thereof
become eminent domain.

10.03      Entire Agreement.
This Agreement constitutes the entire understanding and agreement between the
parties hereto with respect to the Distributorship Patents, the Products and the
other matters contemplated or covered herein. This Agreement supersedes any and
all previous agreements, commitment and understandings, whether oral or written,
between the parties hereto. This Agreement may not be modified, amended or
supplemented except by way of a writing signed by a duly authorized
representative of each of the Parties hereto.

10.04      Assignment.
This Agreement shall not be assignable by either party without the prior written
consent of the other party.

10.05      Notices. Any notice,
request, instruction, report or other document to be given hereunder shall be
given in writing by hand delivery or by posting by certified or Registered mail,
postage prepaid, or by facsimile, receipt confirmed, as follows:

	 	To ANUVU: 	Anuvu Incorporated 
	 	  	 	3980 Research Drive 
	 	  	 	Sacramento, CA 95838 
	 	  	 	  
	 	 	 	Attention:                                                       
	 	  	 	  
	 	To REGI US: 	REGI U.S., Inc. 	
	 	  	 	1103 – 11871 Horseshoe Way 
	 	  	 	Richmond, BC Canada V7A 5H5 
	 	  	 	  
	 	  	 	Attention: Mr. John Robertson, President
    

	Distributorship Agreement 	Page 9 of 11 

or to such other address as a party may specify by notice
hereunder.

10.06      Successors and
Assigns. This Agreement shall be binding upon, and shall inure to the
benefit of, the parties and their respective permitted successors, legal
representatives and assigns.

10.07      Severability. If and
to the extent that any court of competent jurisdiction holds any provision or
part of this Agreement to be invalid or unenforceable, such holding shall in no
way affect the Validity of the remainder of this Agreement.

10.08      Independent
Contractors. The relationship of the parties under this Agreement is that of
independent contractors. Neither party shall be deemed to be the agent of the
other, and neither is authorized to take any action binding upon the other.

10.09      Counterparts. This
Agreement may be executed in counterparts, each of which shall be deemed to be
an original and both together shall be deemed to be one and the same
Agreement.

10.10      Headings. All
headings in this Agreement are inserted for convenience of reference only and
shall not affect its meaning or interpretation.

10.11      Waivers. Any waiver
of any term or condition of or obligation under this Agreement must be set forth
explicitly in writing, signed by the waiving party. A waiver by either party of
any of the terms and conditions of or obligations of the other party under this
Agreement in any instance shall not be deemed or construed to be a waiver of
such term condition or obligation for the future.

10.12      Further Assurances.
ANUVU and REGI US each agree on behalf of themselves and their respective
Affiliates and subREGI USs to produce or execute such other documents or
agreements as may be necessary or desirable for the execution and implementation
of this Agreement and the consummation of the transactions contemplated
hereby.

10.13      Regulatory Approval.
This Agreement shall be subject to any legally required regulatory approvals.
10.14 No Warranty. There is no representations or warranties, express or
implied, other than as expressly set forth or referred to herein and, in
particular, neither Party makes any warranties to each other or any other person
or entity, whether express, implied or statutory, as to the description,
quality, merchantability, completeness or fitness for any purpose of any
services or information provided hereunder or described herein, or as to any
other matter all of which warranties are hereby excluded and specifically
disclaimed.

10.15      Time of the
Essence. The Parties agree that time is of the essence of this Agreement and
further agree that should they fix new times for the performance of any of their
obligations hereunder such new times shall also be of the essence.

10.16      Amendments. No
amendment, modification, alteration or waiver of the terms of this Agreement
shall be binding unless the same shall be in writing dated subsequent to the
date of this Agreement and duly executed by the Parties.

10.17      Captions. The
captions appearing in this Agreement are inserted for convenience of reference
only and shall not effect the interpretation of this Agreement.

IN WITNESS WHEREOF, the parties have caused this
Agreement to be executed by their duly authorized representatives as of the date
first written above.

	for REGI US: 	 	for ANUVU: 
	 	 	 
	 	 	 
	By: 	 	By: 

	Distributorship Agreement 	Page 10 of 11 

.
	Title 	 	Title 
	 	 	 
	 	 	 
		By: 	 
    
	  	 	  Approval of Lender for Anuvu Incorporated 
	 	 	 
	  	 	 
	 	 	Title
    

 

	Distributorship Agreement 	Page 11 of 11Filed by Automated Filing Services Inc. (604) 609-0244 - Fairchild International Corporation - Exhibit 10.1

Exhibit 10.1

2005 NON-QUALIFIED STOCK COMPENSATION PLAN

	1. 	
      PURPOSE OF PLAN

	 	 	 
		1.1 	
      This 2005 NON-QUALIFIED STOCK COMPENSATION PLAN (the
      "Plan") of Fairchild International Corporation, a Nevada corporation (the
      "Company") for employees, directors and consultants of the Company, is
      intended to advance the best interests of the Company by providing those
      persons who have a substantial responsibility for its management and
      growth with additional incentive and by increasing their proprietary
      interest in the success of the Company, thereby encouraging them to
      maintain their relationships with the Company. Further, the availability
      and offering of common stock under the Plan supports and increases the
      Company's ability to attract and retain individuals of exceptional talent
      upon whom, in large measure, the sustained progress, growth and
      profitability of the Company depends.

	 	 	 
	2. 	
      DEFINITIONS

	 	 	 
		2.1 	
      For Plan purposes, except where the context might clearly
      indicate otherwise, the following terms shall have the meanings set forth
      below:

	 	 	 
			
      "Board" shall mean the Board of Directors of the
      Company.

	 	 	 
			
      "Committee" shall mean the Compensation Committee, or
      such other committee appointed by the Board, which shall be designated by
      the Board to administer the Plan, or the Board if no committees have been
      established. The Committee shall be composed of one or more persons as
      from time to time are appointed to serve by the Board. Each member of the
      Committee, while serving as such, shall be a disinterested person with the
      meaning of Rule 16b-3 promulgated under the Securities Exchange Act of
      1934.

	 	 	 
			
      "Common Shares" shall mean the Company's Common Shares,
      $.001 par value per share, or, in the event that the outstanding Common
      Shares are hereafter changed into or exchanged for different shares of
      securities of the Company, such other shares or securities.

	 	 	 
			
      "Company" shall mean Fairchild International Corporation,
      a Nevada corporation, and any parent or subsidiary corporation of
      Fairchild International Corporation

	 	 	 
			
      "Common Stock" shall mean shares of common stock which
      are issued by the Company pursuant to Section 5,
below.

	   
     	
      "Common Stockholder" means the employee of, Consultant,
      or director of the Company or other person to whom shares of Common Stock
      are issued pursuant to this Plan. 

	 	  
	     
     	
      "Common Stock Agreement" means an agreement executed by a
      Common Stockholder and the Company as contemplated by Section 5, below,
      which imposes on the shares of Common Stock held by the Common Stockholder
      such restrictions as the Board or Committee deem appropriate. 

	 	  
	   
     	
      “Consultant” means any person who is contracted to
      provide services to the Company as an independent contractor so long as
      such services are not intended to directly or indirectly promote or
      maintain a market for the Company’s securities. 

	3. 	
      ADMINISTRATION OF THE PLAN

	 	 	 
		3.1 	
      The Committee shall administer the Plan and accordingly,
      it shall have full power to grant Common Stock, construe and interpret the
      Plan, establish rules and regulations and perform all other acts,
      including the delegation of administrative responsibilities, it believes
      reasonable and proper.

	 	 	 
		3.2 	
      The determination of those eligible to receive Common
      Stock, and the amount, type and timing of each grant and the terms and
      conditions of the Common stock agreements shall rest in the sole
      discretion of the Committee, subject to the provisions of the
  Plan.

	 	 	 
		3.3 	
      The Board, or the Committee, may correct any defect,
      supply any omission or reconcile any inconsistency in the Plan in the
      manner and to the extent it shall deem necessary to carry it into
      effect.

	 	 	 
		3.4 	
      Any decision made, or action taken, by the Committee or
      the Board arising out of or in connection with the interpretation and
      administration of the Plan shall be final and conclusive.

	 	 	 
		3.5 	
      Meetings of the Committee shall be held at such times and
      places as shall be determined by the Committee. A majority of the members
      of the Committee shall constitute a quorum for the transaction of
      business, and the vote of a majority of those members present at any
      meeting shall decide any question brought before that meeting. In
      addition, the Committee may take any action otherwise proper under the
      Plan by the affirmative vote, taken without a meeting, of a majority of
      its members.

	 	 	 
		3.6 	
      No member of the Committee shall be liable for any act or
      omission of any other member of the Committee or for any act or omission
      on his own part, including, but not limited to, the exercise of any power
      or discretion given to him under the Plan, except those resulting from his
      own gross negligence or willful misconduct.

		
3.7 		
The Company shall furnish the Committee with such clerical and other assistance as is necessary in the performance of its duties hereunder and such other pertinent information as the Committee may require.

	
	 	 	 
	
4. 		
SHARES SUBJECT TO THE PLAN

	
	 	 	 
		
4.1 		
The total number of shares of the Company available for grants of Common Stock under the Plan shall be one million (1,000,000) Common Shares, subject to adjustment in accordance with Article 7 of the Plan, which shares may be
either authorized but unissued or reacquired Common Shares of the Company.

	
	 	 	 
	
5. 		
AWARD OF COMMON STOCK

	
	 	 	 
		
5.1 		
The Board or Committee from time to time, in its absolute discretion, may award Common Stock to employees of, consultants to, and directors of the Company, and such other persons as the Board or Committee may select. The owner of
such Common Stock shall hold such stock subject to such vesting schedule as the Board or Committee may impose, as determined in the discretion of the Board or Committee.

	
	 	 	 
		
5.2 		
Common Stock shall be issued only pursuant to a Common Stock Agreement, which shall be executed by the Common Stockholder and the Company and which shall contain such terms and conditions as the Board or Committee shall determine
consistent with this Plan, including such restrictions on transfer as are imposed by the Common Stock Agreement.

	
	 	 	 
		
5.3 		
Upon delivery of the shares of Common Stock to the Common Stockholder, below, the Common Stockholder shall have, unless otherwise provided by the Board or Committee, all the rights of a stockholder with respect to said shares,
subject to the restrictions in the Common Stock Agreement, including the right to receive all dividends and other distributions paid or made with respect to the Common Stock.

	
	 	 	 
		
5.4. 		
Notwithstanding anything in this Plan or any Common Stock Agreement to the contrary, no Common Stockholders may sell or otherwise transfer, whether or not for value, any of the Common Stock prior to the date on which the Common
Stockholder is vested therein.

	
	 	 	 
		
5.5 		
All shares of Common Stock issued under this Plan (including any shares of Common Stock and other securities issued with respect to the shares of Common Stock as a result of stock dividends, stock splits or similar changes in the
capital structure of the Company) shall be subject to such restrictions as the Board or Committee shall provide, which restrictions may include, without limitation, restrictions concerning voting rights, transferability of the Common Stock and
restrictions based on duration of employment with the Company, Company performance and individual performance; provided that the Board or Committee may, on such terms and conditions as it may determine to be appropriate, remove

	

		
       
	
      any or all of such restrictions. Common Stock may not be
      sold or encumbered until all applicable restrictions have terminated or
      expire. The restrictions, if any, imposed by the Board or Committee or the
      Board under this Section 5 need not be identical for all Common Stock and
      the imposition of any restrictions with respect to any Common Stock shall
      not require the imposition of the same or any other restrictions with
      respect to any other Common Stock.

	 	 	 
		5.6 	
      In the discretion of the Board or Committee, the Common
      Stock Agreement may provide that the Company shall have the a right of
      first refusal with respect to the Common Stock and a right to repurchase
      the vested Common Stock upon a termination of the Common Stockholder's
      employment with the Company, the termination of the Common Stockholder's
      consulting arrangement with the Company, the termination of the Common
      Stockholder's service on the Company's Board, or such other events as the
      Board or Committee may deem appropriate.

	 	 	 
		5.7 	
      The Board or Committee shall cause a legend or legends to
      be placed on certificates representing shares of Common Stock that are
      subject to restrictions under Common Stock Agreements, which legend or
      legends shall make appropriate reference to the applicable
      restrictions.

	 	 	 
	6. 	
      AMENDMENT AND TERMINATION OF PLAN

	 	 	 
		6.1 	
      The Board may at any time, and from time to time, suspend
      or terminate the Plan in whole or in part or amend it from time to time in
      such respects as the Board may deem appropriate and in the best interest
      of the Company.

	 	 	 
	7. 	
      MISCELLANEOUS PROVISIONS

	 	 	 
		7.1 	
      No person shall have any claim or right to be granted
      Common Stock under the Plan, and the grant of Common Stock under the Plan
      shall not be construed as giving a Common Stockholder the right to be
      retained by the Company.

	 	 	 
		7.2 	
      Any expenses of administering this Plan shall be borne by
      the Company.

	 	 	 
		7.3 	
      Without amending the Plan, grants may be made to persons
      who are foreign nationals or employed outside the United States, or both,
      on such terms and conditions, consistent with the Plan's purpose,
      different from those specified in the Plan as may, in the judgment of the
      Committee, be necessary or desirable to create equitable opportunities
      given differences in tax laws in other countries.

	 	 	 
		7.4 	
      In addition to such other rights of indemnification as
      they may have as members of the Board or the Committee, the members of the
      Committee shall be indemnified by the Company against all costs and
      expenses reasonably incurred by them in connection with any action, suit
      or proceeding to which they or any of them may be party by reason of any
      action taken or failure to act under or in connection with the Plan
      thereunder, and against all amounts paid by them in settlement
    thereof

	     
             	
      (provided such settlement is approved by independent
      legal counsel selected by the Company) or paid by them in satisfaction of
      a judgment in any such action, suit or proceeding, except a judgment based
      upon a finding of bad faith; provided that upon the institution of any
      such action, suit or proceeding a Committee member shall, in writing, give
      the Company notice thereof and an opportunity, at its own expense, to
      handle and defend the same, before such Committee member undertakes to
      handle and defend it on his own behalf.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00091-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00091-of-00352.parquet"}]]